-

United States Biodegradable Plastics Market to 2026 - Forecast by Type, End-user, Raw Materials, Company Analysis & Forecast - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "United States Biodegradable Plastics Market Forecast by Type (Starch Based, PLA, PHA, PBS, PBAT, Others), End-User, Raw Materials, Company Analysis & Forecast" report has been added to ResearchAndMarkets.com's offering.

According to this report the United States Biodegradable Plastics Market is expected to grow with double-digit CAGR and reach US$ 1. 5 Billion by 2026.

Biodegradable plastics are plastics, which can be decomposed into the soil, carbon dioxide, and biomass by the action of living organisms, usually microbes. Usually, biodegradable plastics are manufactured from petrochemicals, microorganisms, recycled raw materials, or all three combinations. New food packaging, dried snacks & candy, bakery products, water & juice cups, and meat trays are widely used in packaging materials made from these plastics. Biodegradable plastics are also used as cup coatings and as drink films & card collection.

A ban on disposable foam food containers and packaging, carryout bag fees, and compulsory collection of plastic recycling may all become part of a nationwide plastic waste bill currently in its early stages. Recently, the government of the United States issued a draft of legislation that they intend to implement in the fall, after collecting suggestions from consumers and companies. The outline of the bill focuses on increasing the duty on plastic manufacturers to handle waste, helping to pay for recycling and raising awareness of plastic environmental footprint that can become garbage. Today various kinds of plastic become garbage such as food containers, cups and lids, plastic cigarette butts, wet wipes, balloons, and lightweight plastic bags. The bill will include opportunities to create less polluting alternatives, although there are no details in the outline.

Research & Development costs also make up a majority of the investment in bio-plastics and affect the prices of materials and goods. Besides, due to pandemic COVID-19 oil prices has hit rock bottom. So because of low oil prices, it currently makes it impossible for bio-plastics to meet competitive market levels as opposed to conventional plastics.

Company Analysis

  • Green Dot Bioplastics
  • DuPont
  • Dow Chemicals
  • Eastman Chemical Company
  • Westrock

Key Topics Covered:

1. Introduction

2. Research Methodology

3. Executive Summary

4. Market Dynamics

4.1 Growth Drivers

4.2 Challenges

5. SWOT Analysis

5.1 Strengths

5.2 Weaknesses

5.3 Opportunities

5.4 Treats

6. Government Initiatives

7. United States Biodegradable Plastics Market

8. Market Share - United States Biodegradable Plastics

8.1 Type

8.2 End-User

9. Type - United States Biodegradable Plastics Market

9.1 Starch Based

9.2 PLA (Polylactic Acid)

9.3 PHA (Polyhydroxyalcanoates)

9.4 PBS (Polybutylene succinate)

9.5 PBAT (polybutylene adipate terephthalate)

9.6 Others

10. End-Users - United States Biodegradable Plastics Market

10.1 Food packaging, dishes, cutlery, bags

10.2 Compost bags

10.3 Foam Packaging

10.4 Agriculture and Horticulture

10.5 Paper coatings

10.6 Others

11. Technological Snapshot

11.1 Biodegradable Production Process

11.2 Biodegradation of Different Polymers by Microorganisms

11.3 Ecotoxicological Studies on Biodegradable Polymers

11.4 Interrelationship between Conventional, Bio-Based and Biodegradable Plastics

12. Raw Material

12.1 List of Raw Materials

12.1.1 Starch Based

12.1.2 PLA (Polylactic Acid)

12.1.3 PHA (Polyhydroxyalcanoates)

12.1.4 PBS (Polybutylene succinate)

12.1.5 PBAT (polybutylene adipate terephthalate)

12.2 Properties of Raw Materials

13. Company Analysis

For more information about this report, visit https://www.researchandmarkets.com/r/2y53s6.

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Research and Markets


Release Versions

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

More News From Research and Markets

SYK Inhibitors Market, Drug Price, Sales & Clinical Trials Outlook, 2030 - Rigel Pharmaceuticals Leads With Fostamatinib and Hutchmed's Sovleplenib Emerges as Late-Stage Breakthrough Candidate for ITP - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "SYK Inhibitors Market, Drug Price, Sales & Clinical Trials Outlook 2030" report has been added to ResearchAndMarkets.com's offering. Report Findings & Highlights: Global SYK Inhibitor Market Growth 2020-2024: 13% CAGR Approved SYK Inhibitor Drugs: 1 Dosage, Price & Sales Insight of Approved Drug Global Market Trend, Size & Future Opportunity Outlook Comprehensive Insight on Global SYK Inhibitors Clinical Pipeline: > 15 Drugs Global SYK Inhibitors...

Brazil Colocation Data Center Portfolio Report/Database 2025-2029: Detailed Analysis of 83 Existing Data Centers, 34 Upcoming Data Centers, and 37 Major Operators/Investors - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Brazil Existing & Upcoming Data Center Portfolio" database has been added to ResearchAndMarkets.com's offering. Brazil's data center landscape is entering a high-growth phase, with upcoming IT load capacity projected to exceed current operational capacity by more than 2.5 times, underscoring strong market expansion and hyperscale demand. Over 34+ upcoming colocation and hyperscale self-built data center projects in Brazil are expected to add over 2.8 GW of capa...

TIGIT Inhibitors Drugs Clinical Trials & Global Market Opportunity Outlook 2026-2030 with Focus on US, China, South Korea, Australia, and Europe - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "TIGIT Inhibitors Drugs Clinical Trials & Global Market Opportunity Outlook 2026" report has been added to ResearchAndMarkets.com's offering. This report tracks developments currently taking place within the sector, providing key insights for investors, researchers, and clinicians are navigating this high risk, high reward market. By examining both the clinical potential and commercial opportunities, this report highlights the strategic relevance of TIGIT inhibi...
Back to Newsroom